Access considerations for a COVID-19 vaccine for South Africa

The novel coronavirus (COVID-19) pandemic is a defining point in human history, having far-reaching effects on all aspects of human life. In the race to find a vaccine, governments need to work collectively to ensure that any life-saving interventions are accessible and affordable to populations acr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bangalee, Varsha, Suleman, Fatima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2020
Materias:
Open Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674376/
https://www.ncbi.nlm.nih.gov/pubmed/33179954
http://dx.doi.org/10.4102/safp.v62i1.5152
_version_ 1783611491327410176
author Bangalee, Varsha
Suleman, Fatima
author_facet Bangalee, Varsha
Suleman, Fatima
author_sort Bangalee, Varsha
collection PubMed
description The novel coronavirus (COVID-19) pandemic is a defining point in human history, having far-reaching effects on all aspects of human life. In the race to find a vaccine, governments need to work collectively to ensure that any life-saving interventions are accessible and affordable to populations across the globe. This pandemic has created an opportunity for international cooperation in working on transparency issues both in terms of sharing manufacturing details to make devices for the diagnosis and treatment of COVID-19 and in terms of clinical trials for therapies that could prove to be effective against the disease.
format Online
Article
Text
id pubmed-7674376
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AOSIS
record_format MEDLINE/PubMed
spelling pubmed-76743762020-11-19 Access considerations for a COVID-19 vaccine for South Africa Bangalee, Varsha Suleman, Fatima S Afr Fam Pract (2004) Open Forum The novel coronavirus (COVID-19) pandemic is a defining point in human history, having far-reaching effects on all aspects of human life. In the race to find a vaccine, governments need to work collectively to ensure that any life-saving interventions are accessible and affordable to populations across the globe. This pandemic has created an opportunity for international cooperation in working on transparency issues both in terms of sharing manufacturing details to make devices for the diagnosis and treatment of COVID-19 and in terms of clinical trials for therapies that could prove to be effective against the disease. AOSIS 2020-10-29 /pmc/articles/PMC7674376/ /pubmed/33179954 http://dx.doi.org/10.4102/safp.v62i1.5152 Text en © 2020. The Authors https://creativecommons.org/licenses/by/4.0/Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License.
spellingShingle Open Forum
Bangalee, Varsha
Suleman, Fatima
Access considerations for a COVID-19 vaccine for South Africa
title Access considerations for a COVID-19 vaccine for South Africa
title_full Access considerations for a COVID-19 vaccine for South Africa
title_fullStr Access considerations for a COVID-19 vaccine for South Africa
title_full_unstemmed Access considerations for a COVID-19 vaccine for South Africa
title_short Access considerations for a COVID-19 vaccine for South Africa
title_sort access considerations for a covid-19 vaccine for south africa
topic Open Forum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674376/
https://www.ncbi.nlm.nih.gov/pubmed/33179954
http://dx.doi.org/10.4102/safp.v62i1.5152
work_keys_str_mv AT bangaleevarsha accessconsiderationsforacovid19vaccineforsouthafrica
AT sulemanfatima accessconsiderationsforacovid19vaccineforsouthafrica

Ejemplares similares